Gold R, Arnold DL, Bar-Or A, Fox RJ, et al. Long-term safety and efficacy of dimethyl fumarate for up to 13 years in patients with relapsing-remitting multiple sclerosis: Final ENDORSE study results. Mult Scler 2021 Sep 1:13524585211037909. doi: 10.1177/13524585211037909.
PMID: 34465252